360 High-Risk Vulnerability Immunization Tool V2.0 vs CVE Tools: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

CVE Tools

Security teams managing sprawling asset inventories will find CVE Tools invaluable for exploit-first vulnerability triage; EPSS scoring and direct links to active GitHub exploits mean you're spending time on vulns that actually have working attack code, not theoretical risk. The platform ingests 320K+ CVEs from NVD, GHSA, CISA KEV, and others with sub-50ms search latency, cutting noise in real vulnerability assessment workflows. Skip this if your workflow is already locked into Rapid7 or Qualys; CVE Tools excels at intelligence prioritization but won't replace a full-stack scanner.